Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sarcoma 32Ovarian Neoplasms 12Leiomyosarcoma 12Liposarcoma 10Neoplasms 7Sarcoma, Ewing 4Neoplasm Metastasis 4Liposarcoma, Myxoid 4Sarcoma, Synovial 3Rhabdomyosarcoma 3Histiocytoma, Malignant Fibrous 3Breast Neoplasms 3Solitary Fibrous Tumors 2Sarcoma, Alveolar Soft Part 2Prostatic Neoplasms 2Osteosarcoma 2Neurofibrosarcoma 2Neoplasms by Site 2Mesothelioma, Malignant 2Malignant mesenchymal tumor 2Ichthyosis, X-Linked 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Bone Neoplasms 2Wilms Tumor 1Uterine Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1

Interventions

exemestane 7Trastuzumab 7Anastrozole 7Letrozole 6Docetaxel 6palbociclib 5pyrotinib 4entinostat 4Fulvestrant 4Cyclophosphamide 4ribociclib 3abemaciclib 3Tamoxifen 3Doxorubicin 3pertuzumab 2Sodium Chloride 2Paclitaxel 2Lapatinib 2Gonadotropin-Releasing Hormone 2Exercise 2Everolimus 2Epirubicin 2Drug Evaluation 2Capecitabine 2Botulinum Toxins, Type A 2Aromatase Inhibitors 2AZD9833 2trastuzumab deruxtecan 1taxane 1sacubitril and valsartan sodium hydrate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Diseases × Trabectedin × Clear all
NCT00050427 2011-04-28

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
53 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡